COVID Vaccine Options Trade with Potential 80% Upside

covid vaccine options

Drug manufacturer Astrazeneca (AZN) is one of many companies working on a COVID-19 vaccine. The company announced on October 12 that the U.S. government has provided it with $486 million in funding to help with the production of its antibody vaccine.

Astrazeneca’s AZD7442 is set to start Phase 3 trials in the next few weeks.

Originally it appeared that investors were investing in pharmaceutical companies thinking that a vaccine would be a big windfall for one company.

Now it looks as though there will be a number of vaccines available within the next year. This means the demand will likely be spread across a number of different products from different companies.

There are some smaller drug companies that saw their stock prices jump sharply when Phase 1 and Phase 2 results were released. But the bigger companies haven’t really seen big boosts when they’ve announced results.

For Astrazeneca, the stock has pretty much stayed on course with a rally that has been ongoing for the last three years.

Looking at the weekly chart for Astrazeneca we see a trend channel going back to the second quarter of 2019. The stock dipped below the lower rail in February and March, and it moved above the upper rail in July.

Other than those two instances, the stock has closed within the channel every week.

The stock is down near the lower rail of the channel currently and the weekly stochastic indicators are close to oversold territory. The indicators are the lowest they have been since early 2019.

What this suggests to me is that the stock is primed for its next leg higher.

Fundamentals better than average

One of the biggest benefits to developing one of the first vaccines for COVID-19 is the opportunity to improve revenue and earnings figures.

For Astrazeneca, the company already has some pretty solid fundamental indicators. The company saw earnings grow by 32% in its most recent quarterly report and they are expected to grow by 35.6% in the next quarter. Analysts expect earnings to grow by 29.6% in 2021.

Revenue was flat in the most recent quarter, but it is expected to increase by 3.6% in the next report. Analysts expect revenue to increase by 7.7% for 2020 and 14.4% in 2021.

In addition to the revenue and earnings growth, the company boasts a return on equity of 31.7% and a profit margin of 20.8%.

Given the upward trend on the chart and the strong fundamentals, I look for Astrazeneca to continue higher over the coming months.

To take advantage of the expected rally, I suggest looking at the January 2021 call options. Specifically I like the 50-strike calls from that option series.

With the stock trading at $55.30 currently, the January 50-strike calls are trading at $7.20. This means that 73% of the premium is intrinsic value and 27% is time premium.

I expect a move similar to what we saw from the end of May ’19 though late July that year, and again from September through December of 2019. In both of those cases the stock rallied right around 20%.

If the stock rallies by 20% from the recent low it would be trading around $63.00. This would make the January 50-strike calls worth at least $13.00 on intrinsic value alone. At the current price, a move to $13.00 would be a gain of just over 80%.

Recommended Articles

‘Healthy’ Foods That Might Be Harming Your Gut and What to Choose Instead

As our world produces and demands more processed foods for convenience, marketers are also getting clever. Foods are being labeled to cater to those with dietary requirements or those looking

5 Surprising Countries Where You Can Retire with Less Than $100,000

When retirement is inching closer, you might wonder about the kind of lifestyle you can lead and the level of financial security you will have if you just have about

fire method for early retirement

The Real Truth About the FIRE Method for Early Retirement

The FIRE method for early retirement has taken off in popularity in recent years. But are the risks well understood by its adopters? Retiring as early as possible then living

Feeling Bloated? 25 Natural Ways to Fix Constipation

We’ve all been there. Things are rumbling in your tummy, you feel big and uncomfortable, but you just can’t seem to poop. Constipation happens to the best of us, and

5 Ways to Ensure You Get the Lowest Possible Mortgage Rate

A 30-year fixed rate mortgage is the most widely chosen home loan option because of the high financial predictability it offers. Follow these tips if you want to obtain the

Robots Will Take 52 Million Americans Jobs. Here’s What Will Happen

A new research report compiled by the Brooking Institution reveals that innovative automation technologies are set to replace millions of American jobs. In fact, more than 52 million American jobs in

Online Loan Companies Are No Easy Fix for Desperate Borrowers

If there is one thing that most Americans need right now, its more money. Online loan companies know this — and it's dangerous for many of us. Since the financial

investing in a volatile market

Investing in a Volatile Market for Long-Term Gains

Investing in a volatile market gives everyone the jitters. Novices, in particular, tend to sell in a panic and then wait for the right time to re-enter the market. Selling

Legumes: Nutrient Dense and Delicious, but Watch for These Preventable Side Effects

Legumes: Good or bad for you? The answer is, a little of both. And at the end of the day, what really matters is how your unique body feels when

4 Keys to Successful Retirement Planning

Retirement planning gives you the freedom to live life to the fullest. You can afford to have all the necessary comforts and amenities of life, go on a vacation occasionally,

Do Seniors Need Life Insurance Coverage?

Do seniors need life insurance coverage? Your golden years should be about enjoying the memories of one’s lifetime. Yet the reality of life is that we struggle to pay our bills

Better Investment Than a Casino? Probably a Fitness Club

We all aspire to be healthier. Who doesn’t aspire to lose weight and exercise more as an annual New Year’s resolution? Yet well-intentioned aspirations and actions are not the same